Skip to main content
Clinical Trials/NCT03604133
NCT03604133RecruitingNot Applicable

Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry

QuesGen Systems Inc1 site in 1 country500 target enrollmentStarted: August 24, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
500
Locations
1
Primary Endpoint
Successful Implantation

Study Overview

Brief Summary

The primary objectives for the registry is to evaluate the overall incidence of serious complications or adverse events for primary implants and replacement devices, and assess the cost and time efficiency for both physicians and patients. The Registry is a multi ASC data collection registry. Data collection will occur at the time of screening, implant, and 2 weeks after implant at the time of wound check.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Physician recommendation to receive the implant in an Ambulatory Surgical Center (ASC)

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Successful Implantation

Time Frame: Two-week follow-up assessment

Patient undergoes surgery for ICD device implantation

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials